Lipid changes after switch from tenofovir disoproxil fumarate to tenofovir alafenamide: a longitudinal cohort study

被引：0
|
作者：
Berger, F. [1 ]
Milinkovic, A. [2 ]
Arenas-Pinto, A. [3 ]
Mauss, S. [1 ]
机构：
[1] Ctr HIV & Hepatogastroenterol, HIV & Hepatogastroenterol, Dusseldorf, Germany
[2] Chelsea & Westminster Hosp, Dept HIV Med, London, England
[3] UCL, Inst Global Hlth, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P195
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
    Laurence Brunet
    Patrick Mallon
    Jennifer S. Fusco
    Michael B. Wohlfeiler
    Girish Prajapati
    Andrew Beyer
    Gregory P. Fusco
    Clinical Drug Investigation, 2021, 41 : 955 - 965
  • [2] Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
    Brunet, Laurence
    Mallon, Patrick
    Fusco, Jennifer S.
    Wohlfeiler, Michael B.
    Prajapati, Girish
    Beyer, Andrew
    Fusco, Gregory P.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (11) : 955 - 965
  • [3] Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV A Cohort Study
    Surial, Bernard
    Mugglin, Catrina
    Calmy, Alexandra
    Cavassini, Matthias
    Gunthard, Huldrych F.
    Stockle, Marcel
    Bernasconi, Enos
    Schmid, Patrick
    Tarr, Philip E.
    Furrer, Hansjakob
    Ledergerber, Bruno
    Wandeler, Gilles
    Rauch, Andri
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : 758 - +
  • [4] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
    Stroffolini, Giacomo
    Dodaro, Valentina
    De Nicolo, Amedeo
    Cusato, Jessica
    Di Perri, Giovanni
    D'Avolio, Antonio
    Boglione, Lucio
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2024, 4 (01):
  • [5] Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV
    Moore, Amelia E. B.
    Burns, James E.
    Sally, Deirdre
    Milinkovic, Ana
    Krokos, Georgios
    John, Joemon
    Rookyard, Christopher
    Borca, Alessandro
    Pool, Erica R. M.
    Tostevin, Anna
    Harman, Alyss
    Dulnoan, Dwight S.
    Gilson, Richard
    Arenas-Pinto, Alejandro
    Cook, Gary J. R.
    Saunders, John
    Dunn, David
    Blake, Glen M.
    Pett, Sarah L.
    AIDS, 2024, 38 (04) : 521 - 529
  • [6] Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
    De Clercq, Erik
    BIOCHEMICAL PHARMACOLOGY, 2016, 119 : 1 - 7
  • [7] Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?
    Aloy, Blandine
    Tazi, Imane
    Bagnis, Corinne Isnard
    Gauthier, Marion
    Janus, Nicolas
    Launay-Vacher, Vincent
    Deray, Gilbert
    Tourret, Jerome
    AIDS REVIEWS, 2016, 18 (04) : 184 - 192
  • [8] A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
    Wassner, Chanie
    Bradley, Nicole
    Lee, Yuman
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2020, 19
  • [9] Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B
    Suzuki, Kazuharu
    Suda, Goki
    Yamamoto, Yoshiya
    Abiko, Satoshi
    Kinoshita, Kenji
    Miyamoto, Shuichi
    Sugiura, Ryo
    Kimura, Megumi
    Maehara, Osamu
    Yamada, Ren
    Kitagataya, Takashi
    Shigesawa, Taku
    Ohara, Masatsugu
    Kawagishi, Naoki
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    PLOS ONE, 2022, 17 (01):
  • [10] Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study
    Wu, Ping-Feng
    Lin, Hsi-Hsun
    Chen, Hsin-Pai
    Huang, Po-Chieh
    Ke, Meng-Yu
    HEALTH SCIENCE REPORTS, 2024, 7 (12)
12345